News|Articles|May 22, 2026
You Can Build AI In-House. But Should You?
Author(s)EVERSANA
Related Content
Trending on PharmExec
1
Where Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?
2
How Behavioral and Engagement Insights Improve Persistence in Patient Support Programs
3
Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results
4
FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report
5